We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.77%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYNA icon
901
Synaptics
SYNA
$4.15B
$576K 0.02%
9,583
+7,001
+271% +$439K
EHTH icon
902
eHealth
EHTH
$43.9M
$575K 0.02%
5,856
+5,804
+11,162% +$675K
EPC icon
903
Edgewell Personal Care
EPC
$1.31B
$575K 0.02%
+18,468
New +$517K
YEXT icon
904
Yext
YEXT
$574M
$575K 0.02%
34,626
+34,559
+51,581% +$485K
KRTX
905
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$575K 0.02%
+5,155
New +$448K
MET icon
906
MetLife
MET
$62.1B
$574K 0.02%
15,727
+7,515
+92% +$262K
CNI icon
907
Canadian National Railway
CNI
$76.6B
$573K 0.02%
6,465
+4,338
+204% +$361K
VIPS icon
908
Vipshop
VIPS
$7.53B
$573K 0.02%
28,801
+16,557
+135% +$284K
AIG icon
909
American International
AIG
$41.3B
$572K 0.02%
18,342
+17,438
+1,929% +$490K
BF.B icon
910
Brown-Forman Class B
BF.B
$13.1B
$572K 0.02%
8,973
+4,225
+89% +$269K
JACK icon
911
Jack in the Box
JACK
$335M
$571K 0.02%
7,704
+7,650
+14,167% +$472K
NJR icon
912
New Jersey Resources
NJR
$5.58B
$568K 0.02%
+17,388
New +$576K
ASND icon
913
Ascendis Pharma A/S
ASND
$16.8B
$567K 0.02%
3,838
+3,379
+736% +$464K
NVR icon
914
NVR
NVR
$17B
$567K 0.02%
174
-661
-79% -$2.03M
SXT icon
915
Sensient Technologies
SXT
$5.53B
$563K 0.02%
10,786
+9,737
+928% +$461K
BRKL
916
DELISTED
Brookline Bancorp
BRKL
$562K 0.02%
+55,809
New +$557K
ADNT icon
917
Adient
ADNT
$1.5B
$561K 0.02%
+34,154
New +$519K
SCHF icon
918
Schwab International Equity ETF
SCHF
$68.7B
$561K 0.02%
+37,712
New +$530K
RXL icon
919
ProShares Ultra Health Care
RXL
$87.7M
$560K 0.02%
19,072
-17,368
-48% -$490K
TGI
920
DELISTED
Triumph Group
TGI
$560K 0.02%
+62,082
New +$459K
FNK icon
921
First Trust Mid Cap Value AlphaDEX Fund
FNK
$231M
$558K 0.02%
20,248
-24,874
-55% -$630K
SEIC icon
922
SEI Investments
SEIC
$12.6B
$558K 0.02%
10,138
-5,172
-34% -$270K
ICF icon
923
iShares Select U.S. REIT ETF
ICF
$2.11B
$557K 0.02%
11,036
-15,792
-59% -$778K
AER icon
924
AerCap
AER
$23.8B
$556K 0.02%
18,051
+7,914
+78% +$226K
ALLO icon
925
Allogene Therapeutics
ALLO
$694M
$556K 0.02%
12,983
+12,919
+20,186% +$467K

Similar funds

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.